NIPRIDE RTU
NDC 51754-1006, Sodium Nitroprusside, injection, solution, from EXELA PHARMA SCIENCES, LLC.
- Product NDC
- 51754-1006
- Status
- Listed
- Labeler
- EXELA PHARMA SCIENCES, LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA209387
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51754-1006 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SODIUM NITROPRUSSIDE.5 mg/mL
Pharmacologic classes
Vasodilation [PE]; Vasodilator [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51754-1006-1 | 51754100601 | 1 VIAL in 1 VIAL (51754-1006-1) / 100 mL in 1 VIAL |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/5acf0836-93ff-4064-b888-3f560e8a558d
Use it
Look up 51754-1006 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51754-1006 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51754-1006. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.